NCCN treatment guidelines for ovarian cancer: A population-based validation study of structural and process quality measures. Presented at: Society of Gynecologic Oncology Annual Meeting on Women's Cancer; Los Angeles, CA; March 11, 2013. Gynecol Oncol. 2013;130(1);e18. Available at: http://...
CE NCCN GUIDELINES® INSIGHTS Ovarian Cancer, Version 1.2019 NCCN: Continuing Education Target Audience: This activity is designed to meet the educational needs All clinicians completing this activity will be issued a certificate of par- of physicians, nurses, pharmacists, and other healthcare pro...
According to the National Comprehensive Cancer Network (NCCN) guidelines (version 1.2023), there are many therapeutic regimens for resistant ovarian cancer, including some novel agents. However, the objective remission rate is still low, and the median survival time is less than 12 months due to c...
According to the National Comprehensive Cancer Network (NCCN) guidelines (version 1.2023), there are many therapeutic regimens for resistant ovarian cancer, including some novel agents. However, the objective remission rate is still low, and the median survival time is less than 12 months due to c...
Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer Objective. To develop an observed-to-expected ratio (O/E) for adherence to National Comprehensive Cancer Network (NCCN) ovarian cancer treatment guidelines... Galvan-Turner, Valerie B...
“NCCN”, the NCCN logo, and “National Comprehensive Cancer Network” are registered trademarks of the National Comprehensive Cancer Network. The Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Ovarian Cancer Guideline 2011 is the Chinese adapted version of NCCN Clinical Practice ...
Patients with advanced ovarian cancer need more effective and targeted drugs. —— NCCN Clinical Practice Guidelines in Ovarian Cancer The latest NCCN guideline recommends a BRCA1/2 or multi-gene detection for high-risk population NCCN guideline recommendation: patients carrying BRCA1/2 gene mutations...
K. et al. NCCN Guidelines® Insights: ovarian cancer, version 3.2022. J. Natl Compr. Canc. Netw. 20, 972–980 (2022). Article PubMed Google Scholar Konstantinopoulos, P. A. et al. Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline. J. Clin. Oncol. ...
Armstrong, D. K. et al. NCCN Guidelines® Insights: ovarian cancer, version 3.2022.J. Natl Compr. Canc. Netw.20, 972–980 (2022). ArticlePubMedGoogle Scholar Konstantinopoulos, P. A. et al. Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline.J. Clin. Onco...
The National Comprehensive Cancer Network (NCCN) guidelines recommend selective resection of all peritoneal surfaces and any metastatic lymph nodes suspected of harboring cancer, as this approach aims to enhance survival rates. Currently, the diagnosis of metastatic lesions primarily relies on laparoscopy,...